CION Cancer Clinics
Residual disease on the surgical specimen | CION Cancer Clinics
Residual disease means cancer that was still present after a treatment. On a surgical report it can mean tumour that survived chemotherapy before the operation and was then removed, or cancer found at the cut edge that may still be in the body. The two are very different, and the first thing to ask your surgeon is which one your report describes. This page explains both and what usually follows. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
On this page
- What does "residual disease" mean on a surgical report?
- The four ways residual disease is described
- Words next to "residual", in plain language
- What happens after residual disease is reported
- Four things families say about residual disease
- What the residual disease line cannot tell you
- Common questions about residual disease after surgery
The short answer
What does "residual disease" mean on a surgical report?
Residual disease means cancer that was still present after a treatment. On a surgical report it is used in two different ways, and you need to know which one your report means before you can understand it.
Meaning one: cancer left in the specimen after pre-surgery treatment
If you had chemotherapy, targeted drugs or radiation before the operation, the pathologist looks at how much living cancer survived it. "Residual" here describes the tumour that remained inside the tissue the surgeon removed. It has been taken out of your body. The report is measuring how well the earlier treatment worked, not what is still inside you.
Meaning two: cancer left behind at the edge of the operation
Sometimes the pathologist finds cancer cells at the cut edge of the specimen (the margin), or the surgeon records that some tumour could not be safely removed. This kind of residual disease may still be in the body, and it is the one that most directly shapes what treatment is advised next.
If you are not sure which meaning your report carries, ask your surgeon that exact question. It is the most useful thing to clear up first.Reading the report
The four ways residual disease is described
Each of these is a different finding and leads to a different conversation.
Residual tumour after treatment before surgery
The cancer shrank but did not disappear. The pathologist grades how much survived, from a few scattered cells to most of the original tumour. This is the most common meaning in breast, rectal and oesophageal cancer.
Microscopic disease at the margin
Cancer cells were found at or very near the cut edge, seen only under the microscope. The surgeon could not have known this during the operation. It raises the chance that a few cells remain.
Usually followed by
- Tumour board discussion
- Radiation to the area, or
- A further, smaller operation
Visible tumour left behind
The surgeon saw cancer that could not be removed, usually because it was wrapped around a vessel or a vital structure. This is written in the operation notes rather than found by the pathologist.
Residual disease in the lymph nodes
After treatment before surgery, the nodes may still contain living cancer even when the main tumour has gone. This is reported separately and often matters more than the tumour itself.
Node results are covered on their own page in this section.Not sure whether this applies to you?
Ask an oncologistOn your report
Words next to "residual", in plain language
- R0, R1, R2
- How complete the removal was. R0 means no cancer at any cut edge. R1 means cancer at the edge seen under the microscope. R2 means tumour the surgeon could see was left behind.
- ypT and ypN
- Staging done by the pathologist after treatment before surgery. The numbers describe how much tumour and node disease was still there.
- Residual cancer burden (RCB)
- A breast cancer score from 0 to 3 for how much cancer survived pre-surgery treatment. 0 means none was found; 3 means a large amount remained.
- Tumour regression grade
- A scale used in bowel, stomach and oesophageal cancer for how much of the tumour was destroyed. Which end of the scale is "good" differs between systems, so ask.
- Treatment effect
- Scarring, dead cells and immune cells where the tumour was. Evidence the treatment reached the area. It is not cancer.
- Close margin
- Cancer near the edge but not at it. Whether that counts as residual depends on the cancer type and how close.
The next few weeks
What happens after residual disease is reported
The surgeon explains which kind it is
Ask directly: is this cancer that was removed, or cancer that may still be in me? Then ask whether it was at the margin, in the nodes, or both.
The tumour board reviews it
Surgical, medical and radiation oncologists look at the amount left, where it sat and your fitness. Residual disease after pre-surgery treatment often leads to a different drug being offered afterwards.
Sometimes a scan or extra tissue test
A scan may be repeated to check the area and the rest of the body. The tissue block may be sent for receptor or gene tests that decide which drug suits the cells that survived.
A plan is explained to you
It may be radiation, more drug treatment, a further operation, or closer follow-up. Ask what each option is trying to achieve and what happens if you choose not to have it.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Four things families say about residual disease
Usually it means the opposite. After chemotherapy before surgery, residual tumour is what survived the drugs and was then removed by the operation. Only a positive margin or a note of tumour left behind means something may remain. Ask which yours is.
A tumour that shrank but did not vanish still responded. Most people treated before surgery have some residual cancer, and the amount left is used to choose the next step. A different drug afterwards is common in exactly this situation.
Sometimes a small further procedure is advised. Often radiation to the area is the answer instead, or the team decides the margin is acceptable for that cancer type. The tumour board weighs this, not the margin line alone.
Residual disease is the reason further treatment exists. Radiation, drug treatment and surgery can each be aimed at what was found. Where an option would not help, the team should say so plainly, and you can ask them to.
When the pathologist cannot find any tumour where one used to be, the report may still describe residual disease elsewhere in the same specimen, for example in a lymph node. The two findings are recorded separately and treated separately.
Being straight with you
What the residual disease line cannot tell you
It cannot tell you how long you will live or whether the cancer will return. It describes what was found in tissue on a particular day. What it means for you depends on the cancer type, the amount and place of what was left, and what treatment is still available.
It cannot be compared across cancers
A small amount of residual tumour in breast cancer after chemotherapy, a positive margin in a mouth cancer, and tumour left near a vessel in pancreatic cancer are three different findings with three different next steps. Read your report against your own cancer type.
It cannot tell you the surgeon made a mistake
Microscopic disease at a margin cannot be seen during the operation. Tumour left near a vital structure is a decision made to protect you on the table. If you have doubts, a second surgical opinion on the report is a fair request and does not offend anyone.
Keep the operation notes as well as the pathology report. When tumour was left behind, it is the operation notes that say where and why.Questions we are asked
Common questions about residual disease after surgery
Is residual tumour still inside me, or was it removed?
If the word describes how much cancer survived treatment given before surgery, it was inside the specimen and has been removed. If the report describes cancer at the margin, or the operation notes say tumour was left behind, some may remain. Ask your surgeon which of these your report means.
Does residual disease mean I will need more chemotherapy?
Often it means further drug treatment is discussed, and in some cancers a different drug is offered after surgery for exactly this finding. It is not automatic. The cancer type, its receptors, how much was left and your fitness all shape the decision at the tumour board.
What is the difference between residual disease and a positive margin?
A positive margin is one kind of residual disease: cancer at the cut edge, which may mean cells remain in the body. Residual tumour inside the specimen after pre-surgery treatment is a different kind: it has been removed, and the report is measuring how the drugs worked.
What does R1 mean and is it serious?
R1 means cancer cells were found at the cut edge under the microscope. It raises the chance that a few cells remain and usually leads to a discussion about radiation or, less often, a further procedure. How much it matters depends on the cancer type and where the margin was.
Why could the surgeon not remove everything?
Usually because the tumour was stuck to a major blood vessel, a nerve or an organ that could not safely be taken. Removing it would have caused more harm than leaving it. The operation notes should say what was left and where, and radiation or drugs can be aimed at it.
Will a scan show whether anything is left?
A scan can show a visible amount of tumour, and it is often repeated after surgery for that reason. It cannot see microscopic cells at a margin. So a clear scan after an R1 result is reassuring but does not change what the microscope found, and the team will plan around both.
What does the residual cancer burden score mean?
It is a breast cancer score combining the size of the surviving tumour, how densely packed its cells are and the node findings. A score of 0 means no cancer was found. Higher scores mean more survived. Your oncologist uses it to decide what drug treatment, if any, follows.
Should I get a second opinion on this report?
It is reasonable whenever a finding is going to change your plan, and residual disease usually does. The slides and block can be read by another pathologist, and the operation notes by another surgeon. Ask your team how to arrange it. Call the helpline if you would like help doing so.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Pathology Reports
- National Cancer Institute — Surgery to Treat Cancer
- Cancer Research UK — Surgery for cancer
- NICE — Early and locally advanced breast cancer: diagnosis and management (NG101)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Not sure which kind of residual disease your report means?
Send us the report and the operation notes, or call the helpline. A surgical oncologist will read them with you and explain what the tumour board will weigh. One helpline serves every CION centre.